INIS
brain
100%
humans
63%
stem cells
61%
proteins
41%
rats
38%
inflammation
37%
neurons
36%
nervous system diseases
35%
levels
34%
genes
33%
epilepsy
30%
administration
30%
diseases
29%
drugs
28%
injuries
25%
hippocampus
24%
blood
22%
aging
20%
therapy
19%
curcumin
19%
mice
18%
animals
15%
oxidation
14%
toxicity
13%
cytokines
12%
doses
12%
control
12%
modulation
12%
morbidity
12%
complement
11%
distribution
11%
populations
11%
pathogenesis
11%
cerebral cortex
10%
homeostasis
10%
tumors
10%
evaluation
10%
reviews
10%
in vitro
9%
dendrites
9%
concentration
9%
mobility
9%
molecules
9%
biological markers
9%
size
8%
bone marrow
8%
mitochondria
8%
shock waves
8%
luminol
8%
blasts
8%
Neuroscience
Neurogenesis
38%
Microglia
37%
Neural Stem Cell
36%
Neurodegenerative Disorder
33%
MicroRNA
28%
Stem Cell
26%
Hippocampus
26%
Status Epilepticus
25%
Cognitive Disorders
24%
Astrocyte
24%
Curcumin
23%
Alzheimer's Disease
21%
Temporal Lobe Epilepsy
17%
Autophagy
16%
Oxidative Stress
13%
Antioxidant
11%
Mesenchymal Stem Cell
11%
Cognitive Function
10%
Cerebral Cortex
10%
Glia
10%
Proinflammatory Cytokine
9%
Neurotrauma
9%
Traumatic Brain Injury
9%
Amyotrophic Lateral Sclerosis
9%
High-Mobility Group
9%
Epileptogenesis
9%
Anti-Inflammatory
9%
Gamma-Aminobutyric Acid
9%
Diagnosis of Parkinson's Disease
8%
Treatment of Parkinson's Disease
8%
Memory Disorder
8%
microRNA 21
8%
Pentraxin 3
8%
Vasculotropin Receptor 3
8%
Cell Therapy
8%
Gene Expression
8%
Metformin
8%
Mitochondrial Function
8%
Leukotriene
8%
Cannabidiol
8%
Neuroprotective Agent
7%
Brain Function
7%
Nervous System Cell
6%
Brain-Derived Neurotrophic Factor
6%
Neurodegeneration
6%
Alpha-Synuclein
5%
Progenitor Cell
5%
Interneuron
5%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
44%
microRNA
31%
Curcumin
22%
Nervous System Inflammation
21%
Alzheimer's Disease
19%
Degenerative Disease
17%
Temporal Lobe Epilepsy
17%
Epileptic State
15%
Inflammation
14%
Amyotrophic Lateral Sclerosis
13%
Biological Marker
11%
Parkinson's Disease
11%
Cognitive Defect
11%
Neoplasm
10%
Brain Dysfunction
10%
Epileptogenesis
9%
Rat Model
9%
4 Aminobutyric Acid
9%
Antioxidant
8%
Pharmacodynamics
8%
Liposome
8%
Anti-Inflammatory Drug
8%
Pharmacokinetics
8%
Juglone
8%
Biodistribution
8%
Pentraxin 3
8%
Luminol
8%
Comorbidity
8%
Esophageal Squamous Cell Carcinoma
8%
Cannabidiol
8%
Memory Disorder
8%
microRNA 21
8%
Traumatic Brain Injury
8%
Transcriptome
8%
Glioblastoma
8%
Drug Repositioning
8%
Histone Deacetylase 1
8%
Ascorbic Acid
8%
Phthalic Acid Bis(2 Ethylhexyl) Ester
8%
Wistar Rat
8%
Symptom
7%
Neuroprotective Agent
6%
Epilepsy
6%
Alpha Synuclein
5%
Clinical Trial
5%